Dopamine is a key neurotransmitter ... of Pittsburgh developed a new mouse strain that enables cell-type-selective deletion of D3 receptors, including in the nucleus accumbens.

Recently, timed-release bromocriptine (Cycloset), a sympatholytic dopamine D 2 receptor agonist, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of type 2 diabetes.

Striatal dopamine (DA) release regulates reward-related learning and behavioural activation and is believed to consist of a short-lived phasic and continuous tonic component. Here, we build a ...